CV2 THE COST-EFFECTIVENESS OF CANDESARTAN IN THE TREATMENT OF CHRONIC HEART FAILURE (HF)—AN ASSESSMENT OF THE LOW LEFT VENTRICULAR EJECTION FRACTION (LOW-LVEF) TRIALS IN THE CANDESARTAN-IN-HEART-FAILURE-ASSESSMENT-OF-REDUCTION-IN-MORTALITYAND-MORBIDITY (CHARM) TRIAL PROGRAMME

✍ Scribed by LÅ Levin; E Jørgensen; B Eriksson; K Swedberg; T Paulsson

• Book ID: 118608760
• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 65 KB
• Volume: 11
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)70065-6